Jolley Asset Management Has Raised Its Novartis Ag (NVS) Holding; Dataram NV (DRAM) Shorts Up By 3.4%

June 1, 2017 - By Adrian Mccoy

Dataram Corporation NV (NASDAQ:DRAM) had an increase of 3.4% in short interest. DRAM’s SI was 511,600 shares in June as released by FINRA. Its up 3.4% from 494,800 shares previously. With 63,300 avg volume, 8 days are for Dataram Corporation NV (NASDAQ:DRAM)’s short sellers to cover DRAM’s short positions. The stock decreased 13.29% or $0.46 during the last trading session, reaching $3. About shares traded. Dataram Corp (NASDAQ:DRAM) has declined 48.17% since June 1, 2016 and is downtrending. It has underperformed by 64.87% the S&P500.

Jolley Asset Management Llc increased Novartis Ag (NVS) stake by 10.5% reported in 2016Q4 SEC filing. Jolley Asset Management Llc acquired 4,324 shares as Novartis Ag (NVS)’s stock rose 4.17%. The Jolley Asset Management Llc holds 45,504 shares with $3.32 million value, up from 41,180 last quarter. Novartis Ag now has $213.39B valuation. The stock increased 1.54% or $1.24 during the last trading session, reaching $81.77. About shares traded. Novartis AG (ADR) (NYSE:NVS) has risen 7.67% since June 1, 2016 and is uptrending. It has underperformed by 9.03% the S&P500.

Dataram Corporation is an independent maker of memory products and well-known provider of performance solutions. The company has market cap of $3.53 million. The Firm provides customized memory solutions for original equipment manufacturers (OEMs) and compatible memory for various brands, as well as a line of memory products for Intel and AMD motherboard based servers. It currently has negative earnings. The Company’s business lines include Dataram/Princeton Memory, Micro Memory Bank (MMB), MemoryStore.com and 18004Memory.com.

Among 13 analysts covering Novartis Ag (NYSE:NVS), 4 have Buy rating, 2 Sell and 7 Hold. Therefore 31% are positive. Novartis Ag had 21 analyst reports since July 28, 2015 according to SRatingsIntel. On Tuesday, April 5 the stock rating was initiated by Argus Research with “Hold”. The firm has “Neutral” rating given on Wednesday, April 19 by JP Morgan. On Tuesday, April 12 the stock rating was downgraded by Morgan Stanley to “Underperform”. The rating was downgraded by Citigroup to “Neutral” on Tuesday, March 29. The company was maintained on Thursday, March 23 by Goldman Sachs. The company was maintained on Friday, March 24 by JP Morgan. The stock of Novartis AG (ADR) (NYSE:NVS) has “Underperform” rating given on Wednesday, October 28 by Mainfirst. The firm has “Neutral” rating by Credit Suisse given on Wednesday, January 11. The rating was upgraded by Argus Research on Thursday, November 10 to “Buy”. On Wednesday, March 8 the stock rating was upgraded by Societe Generale to “Buy”.